bims-gerecp Biomed News
on Gene regulatory networks of epithelial cell plasticity
Issue of 2026–11–01
sixteen papers selected by
Xiao Qin, University of Oxford



  1. Nat Rev Cancer. 2026 Oct 26.
      Single-cell genomics has entered the field of cancer research and clinical oncology, enhancing our understanding of the somatic evolution of cancer and intra-tumour genomic heterogeneity. The evolutionary history of a tumour can be represented as a phylogenetic tree, and in recent years, multiple statistical and computational methods have been proposed to reconstruct tumour phylogenies from single-cell sequencing data. The nature of tumour evolution and of single-cell sequencing, however, raises new challenges in modelling the data and the underlying evolutionary processes that are not addressed by classical phylogenetic and phylodynamic approaches. Here, we review the models and assumptions behind bespoke single-cell tumour phylogeny methods, along with recent computational and algorithmic advances in phylogenetic inference. We discuss the role these advances have in basic and clinical oncology research, and how they provide new insights into individual cancers and cohorts of patient samples. We conclude with an outlook of current challenges for single-cell phylogenetics and potential future applications.
    DOI:  https://doi.org/10.1038/s41568-026-00992-2
  2. Cell Syst. 2026 Oct 28. pii: S2405-4712(26)00241-3. [Epub ahead of print] 101759
      Recent advances in single-cell RNA sequencing and lineage tracing techniques have provided valuable insights into the temporal changes in gene expression during development, tumor progression, and disease onset. However, there are few computational methods available to analyze this information to help understand multicellular dynamics. We introduce Deep Lineage, a deep-learning method for analyzing time-series single-cell RNA sequencing with matched lineage tracing data. Our method accurately predicts early cell fate biases and gene expression profiles at different time points within a clone, surpassing existing methods in fate prediction accuracy. We further validate our model using LineageSim, a fate-aware lineage simulator, demonstrating robustness to technical noise such as barcode dropout and clone misidentification. Additionally, we apply Deep Lineage to in silico perturbations in cellular reprogramming and hematopoiesis to identify key genes and pathways associated with cell fate determination and propose testable perturbation hypotheses for experimental follow-up.
    Keywords:  bioinformatics; cell fate; cellular reprogramming; deep learning; insilico perturbation; lineage tracing; scRNA-seq; single-cell genomics; system biology; time series
    DOI:  https://doi.org/10.1016/j.cels.2026.101759
  3. Curr Opin Chem Biol. 2026 Oct 26. pii: S1367-5931(26)00153-5. [Epub ahead of print]95 102804
      The vast majority of trait-associated genetic variants reside in noncoding cis-regulatory elements (CREs), yet most regulatory sequences remain functionally uncharacterized. CRISPR-based screens enable direct perturbation of CREs in their native genomic context and have expanded into a diverse toolkit, including CRISPRi/CRISPRa, nuclease-mediated editing, base editing, prime editing, and continuous mutagenesis. Moreover, these approaches can be paired with phenotypic, transcriptomic, or chromatin readouts at single-cell resolution. However, a limitation of conventional pooled CRISPR screens is that cells are assigned by sgRNA identity rather than by the genotype installed. New genotype-resolved approaches address this gap by directly reading the edited endogenous sequence. Because sequence variants in CREs are associated with human disease, continued development of CRISPR-based technologies may help advance new therapies. In this review, we discuss diverse CRISPR-based modalities and their limitations, emerging genotype-resolved techniques, their applications in gene therapy, and computational approaches for predicting the function of regulatory sequences.
    DOI:  https://doi.org/10.1016/j.cbpa.2026.102804
  4. Trends Cancer. 2026 Oct 29. pii: S2405-8033(26)00241-4. [Epub ahead of print]
      The rising incidence of early-onset colorectal cancer (EOCRC) challenges existing paradigms of tumorigenesis. Classical models based on cumulative mutational burden, environmental exposure, and hereditary predisposition fail to explain the emergence of malignancy in individuals under 50 years of age. In this review, we propose that EOCRC may be driven by accelerated biological aging and review how core aging processes are prematurely activated in EOCRC. Importantly, these alterations extend beyond the tumor microenvironment and are present in circulating immune cells and inflammatory mediators. We propose that EOCRC develops prematurely in response to environmental, metabolic, genetic, and related factors that systemically accelerate biological aging. This approach reconciles the origin of EOCRC with traditional models of tumorigenesis, while highlighting novel opportunities for early detection, risk stratification, and therapeutic intervention.
    Keywords:  early-onset colorectal cancer; epigenetics; genomics; inflammation; late-onset colorectal cancer; metabolism
    DOI:  https://doi.org/10.1016/j.trecan.2026.10.007
  5. Cell Syst. 2026 Oct 29. pii: S2405-4712(26)00244-9. [Epub ahead of print] 101762
      Inferring hidden cellular dynamics from static single-cell RNA sequencing (scRNA-seq) data remains a critical challenge. Beyond pseudotime trajectories and RNA velocities, cell potency provides another perspective by estimating cellular differentiation potential from gene expression levels. We review 16 computational methods that define cell potency under different, sometimes contrasting, assumptions. On the basis of how they summarize gene expression into a potency measure, we categorize them into average-based, entropy-based, and knowledge-based methods. Using a unified set of mathematical notations, we detail their methodologies, explain key similarities and differences within and between categories, and summarize usage complexities. Given the diversity of methods, community benchmark datasets at single-cell resolution and careful sensitivity analyses are crucial for evaluating methods from multiple angles and potentially improving stability and generalizability. This article provides a basis for method benchmarking and highlights the remaining challenge of comparing methods for inferring pseudotime trajectories, RNA velocities, and cell potency.
    Keywords:  cell differentiation; cell potency; computational methods; developmental potential; interpretability; method categorization; single-cell RNA-seq; stemness
    DOI:  https://doi.org/10.1016/j.cels.2026.101762
  6. Development. 2026 Oct 26. pii: dev.205632. [Epub ahead of print]
      Epithelial morphogenesis is generally attributed to mesenchymal and extracellular matrix interactions, whereas the role of immune cells in tissue assembly remains poorly defined. Here, we established a patient-derived, single-cell 3D hydrogel organoid system to examine immune-epithelial interactions during human mammary morphogenesis. CD45⁺ immune cells integrate into developing breast epithelial structures and persist throughout organoid formation, recapitulating their spatial organization in vivo. Functionally, immune cells act as instructive regulators in a donor-dependent manner, enhancing organoid number, branching, and proliferation. Reciprocal mixing experiments demonstrate that this phenotype is determined by the immune compartment, identifying distinct "inducer" and "non-inducer" states. Live imaging reveals that inducer immune cells undergo directed migration and establish stable early interactions with nascent epithelial clusters, whereas non-inducer cells fail to engage. Although inducer co-cultures produce a pro-morphogenic cytokine environment, soluble factors alone are insufficient to reproduce the phenotype. Instead, TGF-β signaling is required under these conditions, as pathway inhibition attenuates immune-driven morphogenesis whereas exogenous ligand is insufficient. These findings identify immune cells as essential, context-dependent regulators of enhanced epithelial morphogenesis in this organoid system.
    Keywords:  Cell-cell interactions; Extracellular environment Tissue development; Immune-epithelial interactions Organoids; Morphogenesis; Stem cell niche
    DOI:  https://doi.org/10.1242/dev.205632
  7. Trends Cancer. 2026 Oct 30. pii: S2405-8033(26)00244-X. [Epub ahead of print]
    Trends Editorial Team
      
    DOI:  https://doi.org/10.1016/j.trecan.2026.10.010
  8. Cell Stem Cell. 2026 Oct 28. pii: S1934-5909(26)00384-X. [Epub ahead of print]
      The rapid growth of new approach methodologies (NAMs), including organoids and organs-on-a-chip (OOCs), has revealed a need for interdisciplinary dialogue between cell biologists and bioengineers to develop human models that can best complement therapeutic development. Stem cell-derived and bioengineered human tissue models are redefining how we understand human physiology and pathophysiology, offering control that traditional preclinical models cannot provide. By recapitulating complex tissue microenvironments, multi-organ interactions, and patient-specific biology, these systems are bridging long-standing gaps in the drug development and clinical application pipelines. Here, we synthesize advances in organoids, OOCs, and other bioengineered technologies for translational medicine to identify remaining gaps, including challenges in reproducibility, validation, and regulatory acceptance. Emerging opportunities at the intersection of synthetic biology, multi-omics, machine learning, and genetic engineering are positioning NAMs not merely as improved experimental tools but as foundational platforms for accelerating therapeutic discovery and enabling personalized medicine at scale.
    Keywords:  NAMs; bioengineering; iPSCs; organ-on-chip; organoids; translation
    DOI:  https://doi.org/10.1016/j.stem.2026.10.003
  9. Nat Med. 2026 Oct 29.
      The incidence of early-onset colorectal cancer (EO-CRC; diagnosed before age 50 years) is increasing worldwide. Although current data indicate that EO-CRC may be biologically distinct from average-onset CRC (AO-CRC; diagnosed at age ≥50 years), molecular differences remain poorly defined. To address this knowledge gap, we generated a single-nucleus RNA sequencing (snRNA-seq) atlas from 189 primary CRC tumors (54 EO-CRC, 135 AO-CRC) spanning eight decades of life, with at least 20 tumors in most age decades. Our analyses stratified tumors by microsatellite status and accounted for tumor sidedness, stage, patient sex and neoadjuvant treatment history, modeling age continuously or categorically (EO-CRC versus AO-CRC). Among microsatellite-stable (MSS) tumors, those from younger patients were characterized by increased stromal and decreased epithelial proportions, which we confirmed using multispectral immunofluorescence and machine learning in an external cohort of 712 MSS CRC tumors (18 EO-CRC, 694 AO-CRC). Tumor epithelial cells from young patients exhibited increased expression of long noncoding RNAs and FN1, with a trend toward increased heterogeneity in copy number alterations. MSS left-sided EO-CRC tumors had more cell-cell interactions, with epithelial-to-mesenchymal transition-related signaling pathways (FN1/GDF/ACTIVIN) showing increased, cell type-specific interactions. Our large high-resolution snRNA-seq atlas uncovers age-associated features of CRC and provides a resource for the community to understand EO-CRC biology.
    DOI:  https://doi.org/10.1038/s41591-026-04721-y
  10. Development. 2026 Oct 26. pii: dev.205784. [Epub ahead of print]
      Fibroblasts reside underneath most epithelial tissues. In the intestine, recent studies have shown that fibroblast migration contributes to tissue morphogenesis and wound healing. Yet, whether physical interactions between epithelial cells and fibroblasts contribute to epithelial movement remains elusive. Here, we establish a reconstituted epithelial-stromal gap-closure model that enables the study of physical epithelial-fibroblast interactions during intestinal repair. Using this platform, we show that subepithelial fibroblast alignment enhances directed and persistent migration of organoid-derived intestinal epithelia. We demonstrate that direct contact with fibroblasts improves gap closure by promoting cell alignment, sustaining tissue integrity, and synchronizing crypt-villus migration. Fibroblasts undergo long-range ordering to align perpendicularly to the epithelial front and deposit protein paths that act as guidance features to direct epithelial migration. In parallel, epithelial cells acquire a wound-associated epithelial-like phenotype, but insufficient to explain the effects of fibroblast contact. Our findings uncover a dual role for intestinal fibroblasts in epithelial repair, coordinating both biochemical and physical cues to ensure efficient and cohesive migration.
    Keywords:  Epithelial migration; Epithelial-stromal interactions; Intestinal fibroblasts; Matrix alignment; Wound Healing
    DOI:  https://doi.org/10.1242/dev.205784
  11. Trends Cancer. 2026 Oct 30. pii: S2405-8033(26)00239-6. [Epub ahead of print]
      Advancements in in vivo stable isotope tracing have revolutionized our understanding of cancer metabolism, transitioning the field from static metabolomic snapshots to dynamic metabolic pathway activities. However, interpreting raw fractional enrichment data presents significant biological and analytical challenges. This review systematically examines the methodological landscape of in vivo tracing, addressing the interpretive gap created by clinical constraints, such as single-timepoint surgical sampling. We dissect how secondary circulating tracers and the inherent heterogeneity of the tumor microenvironment can confound metabolic signals. We highlight the critical transition to metabolic flux analysis as the requisite computational step to overcome these challenges and to identify targetable metabolic vulnerabilities in precision oncology.
    Keywords:  digital twins; in vivo isotope tracing; isotope tracing in patients; metabolic flux analysis; tumor heterogeneity; tumor metabolism
    DOI:  https://doi.org/10.1016/j.trecan.2026.10.005
  12. Nature. 2026 Oct 28.
      Dynamic interactions between tumours and their microenvironment are crucial for cancer progression and therapeutic outcomes1,2. However, our understanding of these relationships remains limited by the constrained capacity of current human model systems to manipulate diverse cellular components and to interrogate complex tumour-stroma crosstalk. Here we generated combinatorial, mix-and-match tumour assembloids by conditionally reconstituting multiple components of human renal cell carcinoma, including cancer cells, cancer-associated fibroblasts (CAFs) and tumour-infiltrating immune cells. Using genetically engineered renal cell carcinoma assembloids with humanized mouse models, we uncovered mechanisms by which CAFs coordinate interactions between tumour cells and CD8+ T cells to maintain non-cell-autonomous CD8+ T cell stemness and drive responsiveness to anti-PD-1 therapy. These interactions operate through a tumour-CAF-T cell signalling axis in which tumour-derived WNT induces CAF expression of activin A, which enhances CD8+ T cell stemness and sensitivity to PD-1 blockade. In non-responders, we also identified a subset of WNT-unresponsive CAFs that do not produce activin A, which leads to impaired CD8+ T cell stemness and resistance to therapy. Together, these findings establish a tumour-CAF-T cell axis as a key determinant of heterogeneous responses to immune checkpoint inhibitors. Moreover, tumour assembloids provide a versatile platform for mechanistic dissection of the tumour microenvironment and evaluation of personalized immunotherapy strategies.
    DOI:  https://doi.org/10.1038/s41586-026-11208-w